Antimicrobial formularies: Can they minimize antimicrobial resistance?

American Journal of Health-System Pharmacy

Volumn 60, Issue SUPPL. 1, 2003, Pages

  Polk, Ronald E ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Antiinfective agents; Drug use; Formularies; Resistance

Indexed keywords

ANTIBIOTIC AGENT; CEFOTAXIME; CEFTAZIDIME; CLINDAMYCIN; GENTAMICIN; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL COLONIZATION; BACTERIAL STRAIN; CONFERENCE PAPER; DRUG CHOICE; DRUG FORMULARY; DRUG SURVEILLANCE PROGRAM; DRUG USE; HEALTH CARE SYSTEM; INFECTION; INTENSIVE CARE UNIT; MEDICAL DECISION MAKING; MEDICAL INFORMATION SYSTEM; PRIORITY JOURNAL;

EID: 0037616494     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/60.suppl_1.s16     Document Type: Conference Paper

References (9)

1. Wenzel RP, Wong MT. Managing antibiotic use - impact of infection control. Clin Infect Dis. 1999;28:1126-7.
2. White AC Jr, Atmar RL, Wilson J et al. Effects of requiring prior authorization for selected antimicrobials: expenditures, susceptibilities, and clinical outcomes. Clin Infect Dis. 1997; 25:230-9.
3. Landman D, Chockalingam M, Quale JM. Reduction in the incidence of methicillin-resistant Staphylococcus aureus and ceftazidime-resistant Klebsiella pneumoniae following changes in a hospital antibiotic formulary. Clin Infect Dis. 1999; 28:1062-6.
4. Rahal JJ, Urban C, Segal-Maurer S. Nosocomial antibiotic resistance in multiple gram-negative species: experience at one hospital with squeezing the resistance balloon at multiple sites. Clin Infect Dis. 2002; 34:499-503.
5. Burke JP. Antibiotic resistance: squeezing the balloon? JAMA. 1998; 280:1270-1.
6. Rahal JJ, Urban C, Horn D et al. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA. 1998; 280:1233-7.
7. Rice LB. A silver bullet for colonization and infection with methicillin-resistant Staphylococcus aureus still eludes us. Clin Infect Dis. 1999; 28:1067-70.
8. Pujol M, Gudiol F. Evidence for antibiotic cycling in control of resistance. Curr Opin Infect Dis. 2001; 14:711-5.
9. Ronning M, Blix HS, Harbo BT et al. Different versions of the anatomical therapeutic chemical classification system and the defined daily dose - are drug utilisation data comparable? Eur J Clin Pharmacol. 2000; 56:723-7.